Fanapanel

Fanapanel (ZK200775) is a highly selective AMPA/kainate antagonist with little activity against NMDA; have Ki values of 3.2 nM, 100 nM, and 8.5 μM against quisqualate, kainate, and NMDA, respectively.

Product Specifications

CAS Number

[161605-73-8]

Product Name Alternative

ZK200775; MPQX

UNSPSC

12352005

Hazard Statement

H302+H312+H332, H315, H319, H335

Target

IGluR

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/ZK200775.html

Purity

99.51

Solubility

DMSO : 1.25 mg/mL (ultrasonic)

Smiles

O=C(N1CP(O)(O)=O)C(NC(C1=C2)=CC(C(F)(F)F)=C2N3CCOCC3)=O

Molecular Formula

C14H15F3N3O6P

Molecular Weight

409.25

Precautions

H302+H312+H332, H315, H319, H335

References & Citations

[1]Turski L, et al. ZK200775: a phosphonate quinoxalinedione AMPA antagonist for neuroprotection in stroke and trauma. Proc Natl Acad Sci U S A. 1998 Sep 1;95 (18) :10960-5.|[2]Kosowski AR, et al. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551. Psychopharmacology (Berl) . 2004 Aug;175 (1) :114-23.